Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Cardiology/Vascular Diseases | Hematology

Clinical Trials: Venous Thromboembolism


A listing of clinical trials currently looking for volunteers to enroll in Venous Thromboembolism studies. Click on the closest city to find more detailed information on a research study in your area.

Arizona

Glendale : Arrowhead Hospital/Phoenix Heart, PLLC

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Arkansas

Little Rock : Arkansas Children'S Hospital

Pediatric Catheter-related Thrombosis Imaging Study

Little Rock : Arkansas Children's Hospital Research Institute

Treatment of Blood Clots in Children With Cancer

California

Los Angeles :

Rivaroxaban Pharmacokinetics/Pharmacodynamics (PK/PD) Study in Pediatric Subjects

Orange : St. Joseph Hospital

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Palo Alto : Stanford University Medical Center

Treatment of Blood Clots in Children With Cancer

San Diego :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Stanford : Stanford University Medical Center

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Colorado

Aurora : University Of Colorado Denver

Pediatric Catheter-related Thrombosis Imaging Study

Connecticut

Danbury : Danbury Hospital

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Norwich : Eastern Connecticut Hematology and Oncology Associates

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Delaware

Newark : Christiana Care Health Systems

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

District of Columbia

Washington : Georgetown University Lombardi Cancer Center

Treatment of Blood Clots in Children With Cancer

Florida

Jacksonville : Nemours Children's Clinic/Jacksonville

Treatment of Blood Clots in Children With Cancer

Orlando : Florida Hospital

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Tampa : Pepin Heart Hospital / University Community Hospital

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Tampa : St. Joseph's Children's Hospital of TampaPediatric Hematology/Oncology Research Department

Treatment of Blood Clots in Children With Cancer

Vero Beach :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Georgia

Atlanta : Emory University

Treatment of Blood Clots in Children With Cancer

Illinois

Chicago : University of Illinois at Chicago

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Chicago : Rush University Medical Center

Treatment of Blood Clots in Children With Cancer

Hinsdale : Adventist Midwest Health

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Springfield : Prairie Education and Research Cooperative

A Study of the Efficacy of Preventive Dosing of Fondaparinux Sodium Versus Placebo for the Prevention of Venous Thromboembolism (VTE) in Patients Undergoing Coronary Bypass Surgery Receiving Routine Mechanical Prophylaxis

Springfield : Southern Illinois University

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

View More »

Winfield : Central DuPage Hospital

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Indiana

Indianapolis : CorVasc

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Iowa

Iowa City : University of Iowa Carver's College of Medicine

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Kentucky

Florence : St. Elizabeth Healthcare of Northern Kentucky

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Louisvile : Kosair Charities Pediatric Clinical Research Unit- University of Louisville

Treatment of Blood Clots in Children With Cancer

Maine

Portland : Maine Medical Center

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Maryland

Baltimore : Johns Hopkins Bayview Medical Center

A Pilot Study Comparing Enoxaparin to Fondaparinux to Prevent Venous Thromboembolism (VTE) in Bariatric Surgical Patients

Massachusetts

Boston : Massachusetts General Hospital

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Michigan

Ann Arbor : Ann Arbor Veteran's Administration Health System

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Ann Arbor : University of Michigan Medical Center

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Detroit : Henry Ford Health System

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Detroit : Detroit Medical Center

Fondaparinux in Critically Ill Patients With Renal Failure

Minnesota

Rochester : Mayo Clinic

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Missouri

Kansas City : Children'S Mercy Hospital And Clinics

Pediatric Catheter-related Thrombosis Imaging Study

St. Louis : Washington University School of Medicine

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Montana

Butte :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Nebraska

Lincoln : Saint Elizabeth Regional Medical Center

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

New Jersey

Teaneck : Holy Name Hospital

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

New Mexico

Albuquerque : University of New Mexico

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Albuquerque : University of New Mexico

Treatment of Blood Clots in Children With Cancer

New York

Buffalo : Roswell Park Cancer Institute

A Study of Dalteparin Prophylaxis in High-Risk Ambulatory Cancer Patients

New York : Cornell Weill Medical Center

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Rochester : University of Rochester Medical Center

A Study of Dalteparin Prophylaxis in High-Risk Ambulatory Cancer Patients

Rochester : Rochester General Hospital

A Study of Dalteparin Prophylaxis in High-Risk Ambulatory Cancer Patients

Staten Island : Staten Island University Hospital

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

North Carolina

Chapel Hill : University of North Carolina at Chapel Hill

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Durham : Duke University School of Medicine

A Study of Dalteparin Prophylaxis in High-Risk Ambulatory Cancer Patients

Durham : Duke University

Clinical Decision Rule Validation Study to Predict Low Recurrent Risk in Patients With Unprovoked Venous Thromboembolism

Durham : Duke Children's Hospital

Treatment of Blood Clots in Children With Cancer

Winston Salem : Wake Forest University Baptist Medical Center

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

View More »

Winston-Salem : Forsyth Medical Center

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Ohio

Cincinatti : Good Samaritan Hospital

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Cincinnati : Cincinnati Children'S Hospital Medical Center

Pediatric Catheter-related Thrombosis Imaging Study

Cleveland : Cleveland Clinic

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Colombus : Univeristy Medical Center

STA®-Liatest®D-Di-Exclusion of Venous Thromboembolism

Columbus : Riverside Methodist Hospital

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

View More »

Toledo : Jobst Vascular Center

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Oregon

Portland : Oregon Health & Science University

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Portland : Oregon Health and Science University

Treatment of Blood Clots in Children With Cancer

Pennsylvania

West Reading : The Reading Hospital and Medical Center Clinical Trials Office

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

View More »

Bethlehem : St. Luke's Hospital and Health Network

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Philadelphia : Albert Einstein Medical Center

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Philadelphia : Temple University Hospital

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Philadelphia : The Children'S Hospital Of Philadelphia

Pediatric Catheter-related Thrombosis Imaging Study

Pittsburgh : The Western Pennsylvania Hospital

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Pittsburgh : University of Pittsburgh Medical Center Presbyterian Shadyside

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Pittsburgh : Allegheny General Hospital

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Pittsburgh : Children'S Hopsital Of Pittsburgh Of Upmc

Pediatric Catheter-related Thrombosis Imaging Study

West Reading : The Reading Hospital and Medical Center

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Rhode Island

Providence : Rhode Island Hospital

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

South Carolina

Charleston : Medical University of South Carolina

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Charleston : Medical Center of South Carolina

STA®-Liatest®D-Di-Exclusion of Venous Thromboembolism

Tennessee

Memphis : St. Jude Children's Research Hospital

Treatment of Blood Clots in Children With Cancer

Texas

Forth Worth : Cook Children's Medical Center

Treatment of Blood Clots in Children With Cancer

Houston : Texas Children'S Hospital

Pediatric Catheter-related Thrombosis Imaging Study

Houston : Ut Health/Gulf States Hemophilia & Thrombophilia Ctr.

Pediatric Catheter-related Thrombosis Imaging Study

Utah

Salt Lake City : University of Utah

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Virginia

Charlottesville : University of Virginia Health System

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Washington

Tacoma : MultiCare Health System

A Phase 3, Randomized, Parallel-Group, Multi-Center, Multi-National Study for the Evaluation of Efficacy and Safety of (LMW) Heparin/Edoxaban Versus (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis (DVT) and or Pulmonary Embolism (PE).

Wisconsin

Milwaukee : Medical College of Wisconsin/Froedtert Hospital

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Argentina

Buenos Aires : Local Institution

Pediatric Catheter-related Thrombosis Imaging Study

Australia

Parkville :

Rivaroxaban Pharmacokinetics/Pharmacodynamics (PK/PD) Study in Pediatric Subjects

Austria

Graz : 1160.86.43001 Boehringer Ingelheim Investigational Site

Treatment of Patients Undergoing Primary Unilateral Elective Total Knee or Hip Replacement With Dabigatran Etexilate

Many Locations :

Treatment of an Acute Deep Vein Thrombosis (DVT) With Either Rivaroxaban or Current Standard of Care Therapy

Vienna : Local Institution

Pediatric Catheter-related Thrombosis Imaging Study

Wien :

Rivaroxaban Pharmacokinetics/Pharmacodynamics (PK/PD) Study in Pediatric Subjects

Wien : 1160.89.43001 Boehringer Ingelheim Investigational Site

Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of Age

View More »

Wien : 1160.86.43003 Boehringer Ingelheim Investigational Site

Treatment of Patients Undergoing Primary Unilateral Elective Total Knee or Hip Replacement With Dabigatran Etexilate

Belgium

Brussel : 1160.89.32003 Boehringer Ingelheim Investigational Site

Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of Age

Brazil

Valinhos : LAL Clinica Pesquisa e Desenvolvimento Ltda

Efficacy And Safety Of Heparin In Patients With Cardiovascular Surgery Using Cardiopulmonary Bypass

Valinhos : LAL Clinica Pesquisa e Desenvolvimento Ltda

Efficacy And Safety Of Unfractionated Heparin In Patients With Cardiovascular Surgery Using Cardiopulmonary Bypass

Valinhos : Lal Clinica Pesquisa E Desenvolvimento Ltda

Efficacy of Sodium Heparin in Prophylaxis of Venous Thromboembolism in Surgical Patients

Canada

Charlottetown : 1160.86.01003 Boehringer Ingelheim Investigational Site

Treatment of Patients Undergoing Primary Unilateral Elective Total Knee or Hip Replacement With Dabigatran Etexilate

Edmonton : Local Institution

Pediatric Catheter-related Thrombosis Imaging Study

Edmonton :

Rivaroxaban Pharmacokinetics/Pharmacodynamics (PK/PD) Study in Pediatric Subjects

Edmonton : 1160.89.00002 Boehringer Ingelheim Investigational Site

Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of Age

Hamilton :

Rivaroxaban Pharmacokinetics/Pharmacodynamics (PK/PD) Study in Pediatric Subjects

View More »

Hamilton : St Joseph's Healthcare Hamilton

Use of Low Molecular Weight Heparin (Tinzaparin) to Treat Blood Clots in Patients With Kidney Failure

Montreal : SMBD Jewish General Hospital

Clinical Decision Rule Validation Study to Predict Low Recurrent Risk in Patients With Unprovoked Venous Thromboembolism

Montréal : Maisonneuve Rosemont Hospital

STA®-Liatest®D-Di-Exclusion of Venous Thromboembolism

Oshawa : Isis Investigational Site

Active Comparator-Controlled Study to Assess Safety and Efficacy of ISIS FXI Rx in Total Knee Arthroplasty

Ottawa : Ottawa Health Research Institute

Clinical Decision Rule Validation Study to Predict Low Recurrent Risk in Patients With Unprovoked Venous Thromboembolism

Ottawa : Local Institution

Pediatric Catheter-related Thrombosis Imaging Study

Ottawa : 1160.89.00001 Boehringer Ingelheim Investigational Site

Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of Age

Ottawa : Ottawa Hospital, Parkdale Clinic

Use of Low Molecular Weight Heparin (Tinzaparin) to Treat Blood Clots in Patients With Kidney Failure

Red Deer : 1160.86.01001 Boehringer Ingelheim Investigational Site

Treatment of Patients Undergoing Primary Unilateral Elective Total Knee or Hip Replacement With Dabigatran Etexilate

Saskatoon : Saskatchewan Drug Research Institute

Clinical Decision Rule Validation Study to Predict Low Recurrent Risk in Patients With Unprovoked Venous Thromboembolism

Toronto : Local Institution

Pediatric Catheter-related Thrombosis Imaging Study

Toronto : 1160.89.00005 Boehringer Ingelheim Investigational Site

Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of Age

Vancouver : Diamond Health Care Centre

Long-Term Innohep® Treatment Versus a Vitamin K Antagonist (Warfarin) for the Treatment of Venous Thromboembolism (VTE) in Cancer

Czech Republic

Brno : 1160.86.42001 Boehringer Ingelheim Investigational Site

Treatment of Patients Undergoing Primary Unilateral Elective Total Knee or Hip Replacement With Dabigatran Etexilate

Olomouc : 1160.86.42003 Boehringer Ingelheim Investigational Site

Treatment of Patients Undergoing Primary Unilateral Elective Total Knee or Hip Replacement With Dabigatran Etexilate

Prague : 1160.86.42004 Boehringer Ingelheim Investigational Site

Treatment of Patients Undergoing Primary Unilateral Elective Total Knee or Hip Replacement With Dabigatran Etexilate

Prague 5 : 1160.86.42002 Boehringer Ingelheim Investigational Site

Treatment of Patients Undergoing Primary Unilateral Elective Total Knee or Hip Replacement With Dabigatran Etexilate

Denmark

Many Locations :

Treatment of an Acute Deep Vein Thrombosis (DVT) With Either Rivaroxaban or Current Standard of Care Therapy

Finland

Jyväskylä : 1160.86.35801 Boehringer Ingelheim Investigational Site

Treatment of Patients Undergoing Primary Unilateral Elective Total Knee or Hip Replacement With Dabigatran Etexilate

France

Brest : HIA Clermont-Tonnerre

Efficacy of the Association Mechanical Prophylaxis + Anticoagulant Prophylaxis on Venous Thromboembolism Incidence in Intensive Care Unit (ICU)

Brest : Medical Intensive Care Unit

Efficacy of the Association Mechanical Prophylaxis + Anticoagulant Prophylaxis on Venous Thromboembolism Incidence in Intensive Care Unit (ICU)

Castelnau Le Lez : Clinique du Parc CASTELNAU LE LEZ

National Evaluation of the Adherence to Recommendations of Venous Thrombo Embolism Treatment in Cancer Patients

Dijon : University Hospital

STA®-Liatest®D-Di-Exclusion of Venous Thromboembolism

Grenoble : University Hospital

STA®-Liatest®D-Di-Exclusion of Venous Thromboembolism

View More »

Lille : Medical Intensive Care Unit

Efficacy of the Association Mechanical Prophylaxis + Anticoagulant Prophylaxis on Venous Thromboembolism Incidence in Intensive Care Unit (ICU)

Many Locations :

Treatment of an Acute Deep Vein Thrombosis (DVT) With Either Rivaroxaban or Current Standard of Care Therapy

Marseille : 1160.89.33002 Boehringer Ingelheim Investigational Site

Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of Age

Paris : Medical Intensive Care Unit

Efficacy of the Association Mechanical Prophylaxis + Anticoagulant Prophylaxis on Venous Thromboembolism Incidence in Intensive Care Unit (ICU)

Paris : 1160.89.33001 Boehringer Ingelheim Investigational Site

Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of Age

Germany

Freiburg : Local Institution

Pediatric Catheter-related Thrombosis Imaging Study

Hannover : Local Institution

Pediatric Catheter-related Thrombosis Imaging Study

Many Locations :

Treatment of an Acute Deep Vein Thrombosis (DVT) With Either Rivaroxaban or Current Standard of Care Therapy

India

Many Locations :

Xarelto for VTE Prophylaxis After Hip or Knee Arthroplasty

Israel

Tel Hashomer :

Rivaroxaban Pharmacokinetics/Pharmacodynamics (PK/PD) Study in Pediatric Subjects

Italy

Bologna : University Hospital

STA®-Liatest®D-Di-Exclusion of Venous Thromboembolism

Genova :

Rivaroxaban Pharmacokinetics/Pharmacodynamics (PK/PD) Study in Pediatric Subjects

Milan : IRCCS H San Raffaele

STA®-Liatest®D-Di-Exclusion of Venous Thromboembolism

Roma : 1160.89.39001 Boehringer Ingelheim Investigational Site

Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of Age

Japan

Aomori :

Venous Thromboembolism (VTE) Treatment Study in Japanese Deep Vein Thrombosis (DVT) Patients

Bunkyo-ku :

Venous Thromboembolism (VTE) Treatment Study in Japanese Deep Vein Thrombosis (DVT) Patients

Chuoku :

Venous Thromboembolism (VTE) Treatment Study in Japanese Deep Vein Thrombosis (DVT) Patients

Fukuoka :

Venous Thromboembolism (VTE) Treatment Study in Japanese Deep Vein Thrombosis (DVT) Patients

Itabashi-ku :

Venous Thromboembolism (VTE) Treatment Study in Japanese Deep Vein Thrombosis (DVT) Patients

View More »

Kahoku-gun :

Venous Thromboembolism (VTE) Treatment Study in Japanese Deep Vein Thrombosis (DVT) Patients

Kanazawa :

Venous Thromboembolism (VTE) Treatment Study in Japanese Deep Vein Thrombosis (DVT) Patients

Kumamoto :

Venous Thromboembolism (VTE) Treatment Study in Japanese Deep Vein Thrombosis (DVT) Patients

Maebashi :

Venous Thromboembolism (VTE) Treatment Study in Japanese Deep Vein Thrombosis (DVT) Patients

Niigata :

Venous Thromboembolism (VTE) Treatment Study in Japanese Deep Vein Thrombosis (DVT) Patients

Osaka :

Venous Thromboembolism (VTE) Treatment Study in Japanese Deep Vein Thrombosis (DVT) Patients

Osakasayama :

Venous Thromboembolism (VTE) Treatment Study in Japanese Deep Vein Thrombosis (DVT) Patients

Sakura :

Venous Thromboembolism (VTE) Treatment Study in Japanese Deep Vein Thrombosis (DVT) Patients

Sapporo :

Venous Thromboembolism (VTE) Treatment Study in Japanese Deep Vein Thrombosis (DVT) Patients

Sasebo :

Venous Thromboembolism (VTE) Treatment Study in Japanese Deep Vein Thrombosis (DVT) Patients

Shinjuku-ku :

Venous Thromboembolism (VTE) Treatment Study in Japanese Deep Vein Thrombosis (DVT) Patients

Shizuoka :

Venous Thromboembolism (VTE) Treatment Study in Japanese Deep Vein Thrombosis (DVT) Patients

Tokushima :

Venous Thromboembolism (VTE) Treatment Study in Japanese Deep Vein Thrombosis (DVT) Patients

Toyoake :

Venous Thromboembolism (VTE) Treatment Study in Japanese Deep Vein Thrombosis (DVT) Patients

Tsu :

Venous Thromboembolism (VTE) Treatment Study in Japanese Deep Vein Thrombosis (DVT) Patients

Wakayama :

Venous Thromboembolism (VTE) Treatment Study in Japanese Deep Vein Thrombosis (DVT) Patients

Yokohama :

Venous Thromboembolism (VTE) Treatment Study in Japanese Deep Vein Thrombosis (DVT) Patients

Korea, Republic of

Many Locations :

Xarelto Regulatory Post-Marketing Surveillance

Latvia

Riga : 1160.89.37101 Boehringer Ingelheim Investigational Site

Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of Age

Lithuania

Vilnius : 1160.89.37001 Boehringer Ingelheim Investigational Site

Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of Age

Mexico

Col. Secc Xvi Tlalpan : Local Institution

Pediatric Catheter-related Thrombosis Imaging Study

Monterrey : Local Institution

Pediatric Catheter-related Thrombosis Imaging Study

Netherlands

Amsterdam : Local Institution

Pediatric Catheter-related Thrombosis Imaging Study

Nijmegen : 1160.89.31003 Boehringer Ingelheim Investigational Site

Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of Age

Utrecht : 1160.89.31004 Boehringer Ingelheim Investigational Site

Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of Age

Norway

Bergen : 1160.89.47001 Boehringer Ingelheim Investigational Site

Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of Age

Russian Federation

Many locations :

Russian Non-Interventional Study on Compliance of Venous Thromboembolism (VTE)

Spain

Alicante : University Hospital

STA®-Liatest®D-Di-Exclusion of Venous Thromboembolism

Madrid : 1160.89.34002 Boehringer Ingelheim Investigational Site

Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of Age

Madrid : 1160.89.34001 Boehringer Ingelheim Investigational Site

Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of Age

Many Locations :

Treatment of an Acute Deep Vein Thrombosis (DVT) With Either Rivaroxaban or Current Standard of Care Therapy

Soria : General Hospital

STA®-Liatest®D-Di-Exclusion of Venous Thromboembolism

Sweden

Hässleholm : 1160.86.46002 Boehringer Ingelheim Investigational Site

Treatment of Patients Undergoing Primary Unilateral Elective Total Knee or Hip Replacement With Dabigatran Etexilate

Many Locations :

Treatment of an Acute Deep Vein Thrombosis (DVT) With Either Rivaroxaban or Current Standard of Care Therapy

Mölndal : 1160.86.46001 Boehringer Ingelheim Investigational Site

Treatment of Patients Undergoing Primary Unilateral Elective Total Knee or Hip Replacement With Dabigatran Etexilate

Stockholm : Karolinska University Hospital

Compression Treatment Effects on Complications and Healing of Achilles Tendon Rupture

Switzerland

Geneva : Hopitaux Universitaires de Geneve

Clinical Decision Rule Validation Study to Predict Low Recurrent Risk in Patients With Unprovoked Venous Thromboembolism

Many Locations :

Treatment of an Acute Deep Vein Thrombosis (DVT) With Either Rivaroxaban or Current Standard of Care Therapy

Zürich : 1160.89.41001 Boehringer Ingelheim Investigational Site

Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of Age

Thailand

Bangkok : 1160.89.66001 Boehringer Ingelheim Investigational Site

Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of Age

Ukraine

Dnipropetrovsk : 1160.89.38001 Boehringer Ingelheim Investigational Site

Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of Age

Lugansk : 1160.89.38002 Boehringer Ingelheim Investigational Site

Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of Age

Vinnytsya : 1160.89.38003 Boehringer Ingelheim Investigational Site

Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of Age

United Kingdom

Glasgow : Local Institution

Pediatric Catheter-related Thrombosis Imaging Study

London : Local Institution

Pediatric Catheter-related Thrombosis Imaging Study

Vietnam

Many Locations :

Xarelto for VTE Prophylaxis After Hip or Knee Arthroplasty